A PYMNTS Company

US: Pharma management co Catamaran announces acquisition of smaller rival

By  |  August 1, 2013

Pharmacy benefit management company Catamaran announced Thursday it has entered into an agreement to acquire its smaller rival Restat for $409.5 million. Catamaran, which also specializes in pharmaceutical technologies and services, described the deal as a “great opportunity” for the company, as Restat, which is one of the largest private PBM companies and also provides claim processing services, has a core business that “aligns perfectly” with Catamaran’s. Catamaran manages prescriptions for 25 million members.

Full Content: Canada Newswire

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.